We strive for the happiness and better value for everyone
by constantly conducting research activities
Yuyu Mycobutin Capsule
Prescription Drugs
Therapeutic Group
Treatment for Antituberculosis
Active Ingredients
Rifabutin 150mg
1. Inhibition of Mycobacterium avium intracellulare complex (MAC) infection in immunocompromised patients with CD4 lymphocyte count below 200 cells/μL 2. Infectious disease caused by nontuberculous mycobacteria 3. Pulmonary tuberculosis
Adults 1) Inhibition of Mycobacterium avium intracellulare complex (MAC) infection in immunocompromised patients with CD4 lymphocyte count below 200 cells/μL : As rifabutin, 300mg(titer) is administered once a day. For patients with nausea, vomiting, or gastrointestinal tract abnormalities, it is effective to take 150mg(titer) twice a day with food. 2) Infectious disease caused by nontuberculous mycobacteria : It is administered in combination with 450~600mg (titer) per day. The administration is continued for up to 6 months after confirming negative. 3. Pulmonary tuberculosis 150~450mg (titer) per day is administered continuously for at least 6 months. In general, this drug should be administered in combination with other antimycobacterial drugs that do not belong to the rifamycin. 2. Patients with severe renal failure (creatinine clearance less than 30mL/min): Reduce the dose to 1/2 and administer it.
Airtight medicine container, room temperature(1~30℃)
30 capsules(10 capsules/PTPX3)